| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
36,665 |
27,392 |
$1.23M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,835 |
2,244 |
$106K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,088 |
3,660 |
$58K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,542 |
1,818 |
$46K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,795 |
1,608 |
$41K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,410 |
1,302 |
$34K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,021 |
835 |
$28K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
408 |
308 |
$16K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
280 |
239 |
$16K |
| 99334 |
|
1,256 |
891 |
$10K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
110 |
102 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
105 |
92 |
$7K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
89 |
77 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
55 |
51 |
$5K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
40 |
39 |
$4K |
| 99215 |
Prolong outpt/office vis |
33 |
29 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
126 |
108 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
29 |
27 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
25 |
25 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
222 |
159 |
$1K |
| 93000 |
|
58 |
51 |
$958.45 |
| 86756 |
|
69 |
64 |
$918.26 |
| 81002 |
|
482 |
355 |
$787.81 |
| 94060 |
|
16 |
15 |
$648.52 |
| 99173 |
|
36 |
31 |
$260.00 |
| 90734 |
|
14 |
12 |
$240.69 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
231 |
168 |
$231.91 |
| 81005 |
|
74 |
71 |
$163.66 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
19 |
12 |
$150.00 |
| 96160 |
|
64 |
44 |
$94.81 |
| 81025 |
|
16 |
12 |
$65.32 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
337 |
279 |
$40.56 |
| 90633 |
|
34 |
28 |
$36.80 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
64 |
54 |
$25.11 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
86 |
62 |
$1.12 |
| 90670 |
|
111 |
92 |
$0.05 |
| 90680 |
|
17 |
14 |
$0.03 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
52 |
43 |
$0.00 |
| 90649 |
|
12 |
12 |
$0.00 |